We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ACA Likely to Increase Competition, Intensify Enforcement on Drug Access
ACA Likely to Increase Competition, Intensify Enforcement on Drug Access
February 1, 2013
The FDA will watch how the 2010 Affordable Care Act (ACA) boosts competition among drug companies, and increase enforcement against companies bending the rules for competitive advantage, legal experts say.